Can an individual with a low antibody titer (Antibody (Immunoglobulin)) against measles still be immune to measles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, an individual with a low antibody titer against measles can still be immune to measles. Immunity to measles involves both antibody-mediated (humoral) and cell-mediated immune responses. While antibody titers are commonly used to assess immunity, they don't tell the complete story. Some individuals maintain protective immunity through memory B cells and T cells even when circulating antibody levels have declined to low or undetectable levels. This cellular immunity can rapidly produce new antibodies upon re-exposure to the virus. According to the study by 1, evidence indicates that waning immunity is not a major cause of vaccine failure and has little influence on measles transmission. Additionally, revaccination of children who have low levels of measles antibody produces only a transient rise in antibody levels. Key points to consider include:

  • Immunity to measles is not solely dependent on antibody titers
  • Cell-mediated immune responses, such as memory B cells and T cells, can provide protective immunity even with low antibody levels
  • The second dose of MMR vaccine is recommended to reduce primary vaccine failure, rather than to address waning immunity
  • Revaccination may not be necessary for individuals with low antibody titers, unless they are at high risk of exposure. It is essential to consult with a healthcare provider to interpret specific antibody results in the context of vaccination history and risk factors.

From the Research

Measles Immunity and Antibody Titer

  • An individual with a low antibody titer against measles may still be immune to measles, as the level of immunity is not solely determined by the antibody titer 2.
  • A study found that subjects with an EIA-IgG titer of ≥ 12.0 may be protected against measles, while those with a titer of 4.0 to 8.0 may be protected insufficiently and require a booster dose 2.
  • Another study found that the measles-neutralizing antibody titers of individuals who had natural infection were significantly higher than those who received one or two booster doses of the MMR vaccine 3.

Factors Affecting Measles Immunity

  • The avidity of measles-specific IgG antibodies may affect susceptibility to measles virus infection in some vaccinated individuals 4.
  • A study found that the presence of moderate and severe chronic graft-versus-host disease (GVHD) was associated with more rapid loss of immune protection against measles 5.
  • Prior immunization with measles, mumps, and rubella vaccines may contribute to the antibody response to COVID-19 antigens, with measles vaccination triggering cross-reactive B cells 6.

Antibody Titer and Immunity

  • The level of antibody titer does not always correlate with the level of immunity, as other factors such as the avidity of antibodies and the presence of cell-mediated immunity also play a role 2, 4.
  • A low antibody titer does not necessarily mean that an individual is not immune to measles, as the immune system has multiple mechanisms to protect against infection 3, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.